---
layout: post
title: "Prospective Grant of an Exclusive Patent License: Development of Diagnostic for Imaging and Early Detection of Pancreatic Cancer and Pre-Cancerous Lesions by Targeting the Cholecystokinin-B Receptor"
date: 2026-02-05 18:58:48 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-07866
original_published: 2022-04-13 00:00:00 +0000
significance: 8.00
---

# Prospective Grant of an Exclusive Patent License: Development of Diagnostic for Imaging and Early Detection of Pancreatic Cancer and Pre-Cancerous Lesions by Targeting the Cholecystokinin-B Receptor

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** April 13, 2022 00:00 UTC
**Document Number:** 2022-07866

## Summary

The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable, patent license to Georgetown University "Georgetown", a private university located in Washington DC, to its rights to the invention embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/04/13/2022-07866/prospective-grant-of-an-exclusive-patent-license-development-of-diagnostic-for-imaging-and-early)
- API: https://www.federalregister.gov/api/v1/documents/2022-07866

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
